Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy

陳玉紛、葉人華、張慕民、吳宜穎（2018）。The Management of Immune Related Adverse Events Associated with Cancer Immunotherapy。腫瘤護理雜誌，18(1)，29-38。https://doi.org/10.3966/168395442018061801003
黃國埕（2018）。Application of Immune Checkpoint Inhibitor in Cancer Treatment。腫瘤護理雜誌，18(1)，13-27。https://doi.org/10.3966/168395442018061801002
Kim, K. S., Cho, G., Nie, L. F., & Jung, I. H. (2016). State-Dependent Impulsive Control Strategies for a Tumor-Immune Model. Discrete Dynamics in Nature and Society, 2016(), 653-662-058. https://doi.org/10.1155/2016/2979414
Chan, T. H. M., Chen, L., & Guan, X. Y. (2012). Role of Translationally Controlled Tumor Protein in Cancer Progression. Biochemistry Research International, 2012(), 208-212. https://doi.org/10.1155/2012/369384
Chen, P. Y. (2016). Dynamics of Tumor Models and Immunotherapy [master's thesis, Tamkang University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0002-1007201623091200